Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Showing 20 of 0 results

Not applicableUnknownNCT02215577
What this trial is testing

ALPPS Versus PVE/PL

Who this might be right for
Colorectal CancerLiver Metastases
Regionalt Cancercentrum Väst 100
Large-scale testing (Phase 3)Ended earlyNCT05493501
What this trial is testing

Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
EQRx International, Inc. 8
Not applicableEnded earlyNCT01814345
What this trial is testing

Her 2 Testing in Indian Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Tata Memorial Hospital 100
Early research (Phase 1)Study completedNCT03235570
What this trial is testing

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

Who this might be right for
Solid Tumors
Incyte Corporation 44
Testing effectiveness (Phase 2)Study completedNCT00392769
What this trial is testing

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 33
Not applicableEnded earlyNCT02113683
What this trial is testing

Validation of MMS Test for Cancer Monitoring

Who this might be right for
Colo-rectal CancerStomach CancerMelanoma+1 more
MedInnovation GmbH 100
Large-scale testing (Phase 3)Looking for participantsNCT07003074
What this trial is testing

A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 642
Testing effectiveness (Phase 2)Study completedNCT00632723
What this trial is testing

IRESSA™ (Gefitinib) in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 54
Not applicableWithdrawnNCT00518635
What this trial is testing

Low Dose Growth Hormone in Obese PCOS Women

Who this might be right for
Polycystic Ovary Syndrome
Oregon Health and Science University
Testing effectiveness (Phase 2)Looking for participantsNCT07485452
What this trial is testing

Boosting Osimertinib Blood Brain Barrier Penetration

Who this might be right for
Non-Small Cell Lung Cancer
Maastricht University Medical Center 7
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT02871791
What this trial is testing

Palbociclib With Everolimus + Exemestane In BC

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHormone Receptor (HR)-Positive Breast Cancer
Dana-Farber Cancer Institute 41
Early research (Phase 1)Study completedNCT02562378
What this trial is testing

T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
MedSIR 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03381274
What this trial is testing

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

Who this might be right for
Carcinoma, Non-Small-Cell Lung
MedImmune LLC 43
Large-scale testing (Phase 3)Looking for participantsNCT06350097
What this trial is testing

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 582
Early research (Phase 1)Study completedNCT01340040
What this trial is testing

Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects

Who this might be right for
CancerAdvanced Solid Malignancies
AstraZeneca 10
Large-scale testing (Phase 3)Study completedNCT01702571
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,185
Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Not applicableStudy completedNCT01852487
What this trial is testing

Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia

Who this might be right for
Androgenic Alopecia
Dream Plus 80
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation